E-learningNews & eventsSpeakersPartners
Sign in
Sign in
Social media
Main pages
  • News & events
  • Speakers
  • Partners
  • Reviews
E-learning
  • Courses
  • Lectures
Corporate website
  • Sona Group

Contacts

  • info@sona-pharm.eu
  • Business days 9:00-17:00 EET
  • +372 505 9699
  • Ahtri 6, Tallinn, 10151, Estonia

Sona Group unites a network of independent pharmaceutical and healthcare companies operating in research, manufacturing and continued medical education.

This website is intended for informational and corporate communication purposes only and is not a substitute for medical advice.

© 2026 Sona Academy®. All rights reserved.

··Site map
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
  • Legal Notice
  • Professional Medical Disclaimer
  • Data Collection and Privacy Disclaimer
  1. Home
  2. /
  3. All courses
  4. /
  5. Endometrial preparation, receptivity and emerging tech in IVF.
  6. /
  7. Direct embryo transfer: a new automated technique
Reproductive healthLecture

Direct embryo transfer: a new automated technique

How much of IVF failure happens after the transfer catheter leaves the cervix? An unpublished preview of next-generation embryo transfer — robotic microfluidic injection into a defined endometrial pocket under image guidance, on the way to first-in-human trials.

Carlos Simon
Carlos Simon
Audio: MultiSubtitles: EN · UA · RU21 min
Carlos Simon

Carlos Simon

Professor, MD, PhD

Professor of Obstetrics and Gynecology at the University of Valencia and Founder of the Carlos Simón Foundation for Research in Women's Health. Internationally recognized for his pioneering work on the human endometrium and endometrial receptivity, including the development of the Endometrial Receptivity Array (ERA). Recipient of the ASRM Distinguished Researcher Award and author of more than 500 scientific publications.

Valencia, SpainLinkedIn →

What was shown

An unpublished preview of a next-generation embryo transfer system. Classical transfer is operator-dependent and outcome is shaped by injection velocity, intrauterine pressure and medium viscosity — variables the embryologist cannot control once the catheter leaves the cervix. The proposed direct-injection system uses a 2.1 mm catheter with on-board camera, micro-injection needle plunger, capacity sensing for endometrial localisation, and live image guidance to deposit the embryo at a defined intra-endometrial depth.

Key findings

After classical transfer the embryo position predicts the implantation site only 50% of the time. In 23-57% of cases methylene-blue flows back through the cervix during a standard injection. The system has cleared a primate preclinical safety study (Macaca mulatta, Oregon Primate Center) and a feasibility study in hysterectomised human uteri (Valencia). Regulatory approval from the European Medical Agency has been obtained; first-in-human trials are scheduled to start in two Spanish clinics in October 2024.

What this means in practice

Classical embryo transfer technique remains the standard for now. The concept reframes the next bottleneck after embryo selection as the act of transfer itself: 'one euploid embryo, one baby at home'. Follow the first-in-human results expected over the next 2 years before drawing clinical conclusions.

Caveats

The animal cervix is a poor analogue of the human, so feasibility data in primates needs replication in human trials. Direct intra-endometrial injection raises questions about local trauma, infection risk and how it interacts with HRT versus natural-cycle endometrium. The technology is preclinical-to-investigational; it is not a current treatment option.

Topics covered

  • Limitations of classical embryo transfer
  • Intrauterine pressure and viscosity
  • Direct intra-endometrial embryo injection
  • Robotic and microfluidic transfer system
  • Live imaging in transfer
  • One euploid embryo, one baby concept
  • Primate preclinical safety study
  • First-in-human regulatory pathway
Course

Endometrial preparation, receptivity and emerging tech in IVF.

View course

Related lectures

  • Personalizing LH supplementation in female infertility: which patients may benefitLH in reproductive medicine: personalized approaches in female and male infertility.
  • Personalizing gonadotropin treatment in male infertility: how APHRODITE may helpLH in reproductive medicine: personalized approaches in female and male infertility.
  • Why euploid embryos fail to implant?Why do euploid embryos fail to implant.
Carlos Simon

Carlos Simon

Professor of Obstetrics and Gynecology at the University of Valencia and Founder of the Carlos Simón Foundation for Research in Women's Health. Internationally recognized for his pioneering work on the human endometrium and endometrial receptivity, including the development of the Endometrial Receptivity Array (ERA). Recipient of the ASRM Distinguished Researcher Award and author of more than 500 scientific publications.

Author of the lecture "Direct embryo transfer: a new automated technique"